• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS AFP ASSAY; KIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS AFP ASSAY; KIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER Back to Search Results
Model Number AFP
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/13/2022
Event Type  malfunction  
Event Description
The initial reporter questioned high results not corresponding to the clinical picture for 1 patient tested for elecsys afp assay (afp) on a cobas 8000 e 602 module.The results were believed to be too high as the patient has no signs or symptoms of any disease; other results (thyroid, other tumor markers) and examinations (routine blood and b-ultrasonic) showed no abnormalities.The patient is healthy and has no other known disease.The patient does not take any medication and does not receive any treatment.It is not known if the patient takes any dietary supplements.The initial result from the e602 module was 30956 ng/ml.The sample was repeated with a result of 36091 ng/ml.Another result from the e602 module was allegedly 33639 ng/ml.The results were reported outside of the laboratory.The afp results were reported to be similar using other methods.The e602 module serial number was (b)(4).
 
Manufacturer Narrative
Medwatch field address 2 continued: (b)(6).The customer suspected an interference and performed a polyethylene glycol precipitation (peg) experiment and a spike experiment using calf serum: the peg experiment result was 16433 ng/ml.The calf serum experiment result was 6928 ng/ml.Calibration was last performed on (b)(6) 2022 and was acceptable.In this case, calibration was last performed 4 months ago.Product labeling states: renewed calibration is recommended as follows: after 1 month (28 days) when using the same reagent lot.After 7 days (when using the same reagent kit on the analyzer).As required: e.G.Quality control findings outside the defined limits.The qc material used by the customer expired in apr-2021.The measuring cells were last replaced in (b)(6) 2021.Sample material from the patient was requested for investigation.The investigation is ongoing.
 
Manufacturer Narrative
Medwatch field b6 was updated.The patient does not have liver disease (eg: liver cancer, alcoholic liver disease), hepatitis, cirrhosis or any type of ovarian cancer.It was clarified that the patient does not take any dietary supplements or traditional medicine.
 
Manufacturer Narrative
The patient sample was received for investigation.The customer's high results were reproduced during the investigation (> 30000 ng/ml).A dilution experiment was performed with good linearity results; there were no signs of an interference and no implausible results.The sample was tested by the elecsys method and the elisa method and similar results were obtained: a mean result 40096 ng/ml (elecsys) and a mean result of 31620 ng/ml (elisa).The investigation noted that the experiments performed by the customer also do not indicate an interference.It is possible for healthy adults to have elevated afp results that may be caused by the hereditary persistence of -fetoprotein (hpafp).Based on the information available, there is no evidence of an interference in the patient sample causing the high afp results.The investigation determined the high afp results, in this case, are considered to be the true results.The investigation did not identify a product problem.The specific cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS AFP ASSAY
Type of Device
KIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15159577
MDR Text Key304818056
Report Number1823260-2022-02283
Device Sequence Number1
Product Code LOJ
UDI-Device Identifier04015630920716
UDI-Public04015630920716
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K981282
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2023
Device Model NumberAFP
Device Catalogue Number04481798190
Device Lot Number559382
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-